[ET Net News Agency, 3 December 2024] EVEREST MED-B (01952) rose 10.8% to HK$45.
It hits an intra-day high of HK$45.05, hitting a 52-week high, and an intra-day low of
HK$39.95. The total shares traded was 6.56 million, with a value of HK$282.31m. The active
buy/sell ratio is 67:33, with net buying turnover of HK$90.72m. MACQUARIE CAPITAL accounts
for greatest net responsive buying turnover of HK$4.87m, with volume weighted average
price of HK$42.888. CHINA INV INFO accounts for greatest net responsive selling turnover
of HK$11.51m, with volume weighted average price of HK$43.253. The stock has risen a
combined 31.2% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 45.000 % Chg +10.84%
High 45.050 Low 39.950
Shares Tr 6.56m Turnover 282.31m
10-D SMA 38.475 %H.V 101.114
20-D SMA 36.738 VWAP 43.048
50-D SMA 31.611 RSI14 67.850
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 67:33, with net buying turnover
of HK$90.72m, rising a combined 31.2% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 45.00 +10.84
GENSCRIPT BIO (01548) 10.98 +2.62
INNOVENT BIO (01801) 38.30 -0.91
WUXI BIO (02269) 15.84 +2.19
WUXI APPTEC (02359) 50.15 +2.24
BEIGENE (06160) 123.80 -2.44
ASCENTAGE-B (06855) 40.35 -3.81
SKB BIO-B (06990) 190.30 +2.81
ZAI LAB (09688) 23.50 +4.44
AKESO (09926) 70.10 -2.64
---------------------------------------------
(ed)